Daniel Gordon Kirby - 10 Feb 2025 Form 3 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Chief Commercial Officer
Signature: /s/ Daniel Gordon Kirby
Issuer symbol: IOVA
Transactions as of: 10 Feb 2025
Net transactions value: $0
Form type: 3
Filing time: 12 Feb 2025, 17:15:18 UTC
Next filing: 06 Jun 2025
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

1. On February 10, 2025, Daniel Gordon Kirby joined Iovance Biotherapeutics, Inc. (the "Issuer") as its Chief Commercial Officer.